# Immix Biopharma, Inc.: Form DEF 14A, filed Apr 25, 2023

- Company: [Immix Biopharma, Inc.](/companies/immx.md) (CIK 1873835)
- Form: DEF 14A
- Filed: 2023-04-25
- Accepted by EDGAR: Apr 25, 2023, 16:52 ET
- Period: 2023-04-25
- Accession: 0001493152-23-013537
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1873835/000149315223013537/formdef-14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1873835/000149315223013537/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1873835/000149315223013537/formdef-14a.htm

Filed Apr 25, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-013537. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.